
sis of cervical cancer. Our innovative two-stage CNN
method represents a significant contribution to this
domain. In the first stage, we employ a swift and high-
precision model for cell detection, achieving preci-
sion rates exceeding 90%. This initial stage ensures
prompt identification of cells, effectively reducing the
computational overhead.
In the second stage, we leverage the power of the
ResNet-50 architecture, renowned for its exceptional
top-1 accuracy and efficiency, to perform cell clas-
sification. By employing this pre-trained model, we
not only enhance accuracy but also optimize compu-
tational resources, streamlining the classification pro-
cess, but our journey was not without its challenges.
During our work, we encountered the issue of overfit-
ting in the ResNet-50 model. However, our commit-
ment to excellence and the early recognition of this
challenge allowed us to swiftly address it by introduc-
ing a dropout layer with a rate of 0.3 in the flattened
layer of ResNet-50 architecture. This correction en-
sured that our model not only excelled in accuracy
but also maintained its robustness, further enhancing
its reliability.
This approach aligns with the World Health Orga-
nization’s objectives for cervical cancer screening, as
it expedites the analysis while maintaining high ac-
curacy standards. Our work is not only a technologi-
cal advancement but a potential game-changer in the
field of medical diagnostics, as it holds the promise of
accelerating the detection and, subsequently, the pre-
vention of cervical cancer.
Looking ahead, future research endeavors could
explore further improvements in the scanning pro-
cess, offering even greater efficiency and accuracy.
Additionally, expanding the dataset for training mod-
els may yield enhanced results, reinforcing the ro-
bustness of the method. Despite the limitation of a
small dataset, we can confidently assert that our mod-
els have been successfully trained, marking a pivotal
step toward a future where the early and accurate de-
tection of cervical cancer is not only achievable but
a cornerstone in global healthcare. Our contribution
paves the way for a world where cervical cancer is
no longer an insurmountable threat, but a preventable
and treatable disease.
REFERENCES
(2018). Instituto nacional de estad
´
ıstica y censos.
(2021). Cervical cancer ecuador 2021 country profile.
Alsalatie, M., Alquran, H., Mustafa, W. A., Mohd Yacob,
Y., and Ali Alayed, A. (2022). Analysis of cytology
pap smear images based on ensemble deep learning
approach. Diagnostics, 12(11):2756.
Chen, L., Gautier, P., and Aydore, S. (2020). Dropcluster: A
structured dropout for convolutional networks. arXiv
preprint arXiv:2002.02997.
Davies-Oliveira, J., Smith, M., Grover, S., Canfell, K.,
and Crosbie, E. (2021). Eliminating cervical cancer:
Progress and challenges for high-income countries.
Clinical Oncology, 33(9):550–559. Latest Advances
in Endometrial and Cervical Cancer - A Global View.
Elyan, E., Vuttipittayamongkol, P., Johnston, P., Martin, K.,
McPherson, K., Jayne, C., Sarker, M. K., et al. (2022).
Computer vision and machine learning for medical
image analysis: recent advances, challenges, and way
forward. Artificial Intelligence Surgery, 2.
Franco, E. L., Duarte-Franco, E., and Ferenczy, A. (2001).
Cervical cancer: epidemiology, prevention and the
role of human papillomavirus infection. Cmaj,
164(7):1017–1025.
Ghoneim, A., Muhammad, G., and Hossain, M. S. (2020).
Cervical cancer classification using convolutional
neural networks and extreme learning machines. Fu-
ture Generation Computer Systems, 102:643–649.
Hasenleithner, S. O. and Speicher, M. R. (2022). How to
detect cancer early using cell-free dna. Cancer Cell,
40(12):1464–1466.
He, F., Liu, T., and Tao, D. (2020). Why resnet works?
residuals generalize. IEEE transactions on neural net-
works and learning systems, 31(12):5349–5362.
Hussain, E., Mahanta, L. B., Borah, H., and Das, C. R.
(2020). Liquid based-cytology pap smear dataset for
automated multi-class diagnosis of pre-cancerous and
cervical cancer lesions. Data in Brief, 30:105589.
Koh, D.-M., Papanikolaou, N., Bick, U., Illing, R., Kahn Jr,
C. E., Kalpathi-Cramer, J., Matos, C., Mart
´
ı-Bonmat
´
ı,
L., Miles, A., Mun, S. K., et al. (2022). Artificial
intelligence and machine learning in cancer imaging.
Communications Medicine, 2(1):133.
Kurniawati, Y. E., Permanasari, A. E., and Fauziati, S.
(2016). Comparative study on data mining classifica-
tion methods for cervical cancer prediction using pap
smear results. In 2016 1st International Conference
on Biomedical Engineering (IBIOMED), pages 1–5.
IEEE.
Macancela, C., Morocho-Cayamcela, M. E., and Chang, O.
(2023). Deep reinforcement learning for efficient dig-
ital pap smear analysis. Computation, 11(12).
Rezende, M. T., Silva, R., de O. Bernardo, F., Tobias, A.
H. G., Oliveira, P. H. C., Machado, T. M., Costa, C. S.,
Medeiros, F. N. S., Ushizima, D. M., Carneiro, C. M.,
and Bianchi, A. G. C. (2021). Cric searchable im-
age database as a public platform for conventional pap
smear cytology data. Scientific Data, 8(1).
Rom
´
an, K., Llumiquinga, J., Chancay, S., and Morocho-
Cayamcela, M. E. (2023). Hyperparameter tuning
in a dual channel u-net for medical image segmenta-
tion. In Maldonado-Mahauad, J., Herrera-Tapia, J.,
Zambrano-Mart
´
ınez, J. L., and Berrezueta, S., editors,
Information and Communication Technologies, pages
337–352, Cham. Springer Nature Switzerland.
Sompawong, N., Mopan, J., Pooprasert, P., Himakhun, W.,
Suwannarurk, K., Ngamvirojcharoen, J., Vachiramon,
ICSOFT 2024 - 19th International Conference on Software Technologies
226